Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Initial and follow up imaging in paraneoplastic rhombencephalitis from Hodgkin’s lymphoma
Neuro-oncology
P4 - Poster Session 4 (5:30 PM-6:30 PM)
13-004
We discuss MRI brain findings at initial diagnosis as well as in longitudinal follow up after diagnosis and treatment for Hodgkin’s lymphoma presenting as paraneoplastic rhombencephalitis. 
Paraneoplastic rhombencephalitis is a rare disorder and MRI brain findings are not clearly characterized. While case series have described no clear MRI findings, several reports have described high intensity MRI signal changes in the rhombencephalon.  It is not clear how these MRI findings, when present, evolve with time and in the setting of treatment of the underlying neoplastic and autoimmune processes. 
N/A

A 59-year-old man presented with vertigo and vomiting from another facility where he was treated with IVIG. Exam revealed normal vital signs, abulia, bradyphrenia, rotatory and vertical nystagmus, dysarthria, rigidity, ataxia, and weakness. Initial MRI showed a T2 hyperintensity in the midbrain and pons, without any enhancement. CSF revealed lymphocytic pleocytosis with atypical cells and normal protein. CT chest revealed L axillary lymphadenopathy and biopsy revealed nodular sclerosing Hodgkin’s lymphoma. There was notable improvement with plasmapheresis. He underwent 6 cycles of Doxorubicin, Bleomycin, Vinblasinte, and Dacarbazine. The abnormal MRI signal resolved and there was cerebellar atrophy noted at the fourteen and eighteen months follow up imaging.

The exact reason for these changes is unclear. It is possible that the hyperintensity on imaging was related to the neoplastic or paraneoplastic process and resolved upon treatment. Alternatively, the paraneoplastic process and exam findings pointed to cerebellar involvement which underwent an insult, and the initially hyperintense areas atrophied. The role of the specific treatment modalities cannot be confirmed, and further investigations are needed.

Authors/Disclosures
Rebecca L. Hurst, MD (USF College of Medicine)
PRESENTER
Dr. Hurst has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Paul Wilkinson law firm.
Tigran Kesayan, MD (VUMC Pain Medicine and Neurology) Dr. Kesayan has nothing to disclose.